These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10451571)

  • 1. [Autotransplantation of hematopoietic progenitor cells in multiple sclerosis].
    Fernández J; Correale J; Campestri R; Koziner B
    Medicina (B Aires); 1999; 59(3):287-92. PubMed ID: 10451571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience.
    Fassas A; Kimiskidis VK
    J Neurol Sci; 2004 Aug; 223(1):53-8. PubMed ID: 15261561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.
    Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY
    Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis].
    Saiz A; Blanco Y; Berenguer J; Gómez-Choco M; Carreras E; Arbizu T; Graus F
    Neurologia; 2008 Sep; 23(7):405-7. PubMed ID: 18726717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients.
    Ni XS; Ouyang J; Zhu WH; Wang C; Chen B
    Clin Transplant; 2006; 20(4):485-9. PubMed ID: 16842526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation in multiple sclerosis.
    Rogojan C; Frederiksen JL
    Acta Neurol Scand; 2009 Dec; 120(6):371-82. PubMed ID: 19785643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.
    Van Wijmeersch B; Sprangers B; Dubois B; Waer M; Billiau AD
    J Neuroimmunol; 2008 Jul; 197(2):89-98. PubMed ID: 18541311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
    Brinker BT; Waller EK; Leong T; Heffner LT; Redei I; Langston AA; Lonial S
    Cancer; 2006 May; 106(10):2171-80. PubMed ID: 16598756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for multiple sclerosis: finding equipoise.
    Burt RK; Kozak T
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S45-8. PubMed ID: 12931241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?
    Fassas A; Mancardi GL
    Autoimmunity; 2008 Dec; 41(8):601-10. PubMed ID: 18958762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis].
    Kozák T; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
    Cas Lek Cesk; 2000 May; 139(9):263-6. PubMed ID: 10953423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.
    Shevchenko YL; Novik AA; Kuznetsov AN; Afanasiev BV; Lisukov IA; Kozlov VA; Rykavicin OA; Ionova TI; Melnichenko VY; Fedorenko DA; Kulagin AD; Shamanski SV; Ivanov RA; Gorodokin G
    Exp Hematol; 2008 Aug; 36(8):922-8. PubMed ID: 18468768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis].
    Créange A; Farge-Bancel D
    Rev Neurol (Paris); 2008 Mar; 164(3):207-15. PubMed ID: 18405770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic SCT for the treatment of multiple sclerosis.
    Atkins H
    Bone Marrow Transplant; 2010 Dec; 45(12):1671-81. PubMed ID: 20697363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis.
    La Nasa G; Littera R; Cocco E; Battistini L; Marrosu MG; Contu L
    Ann Hematol; 2004 Jun; 83(6):403-5. PubMed ID: 14648027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.